Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.

Tiev KP, Coste J, Ziani M, Aubourg F, Cabane J, Dinh-Xuan AT.

Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(1):32-8.

PMID:
19960786
2.

Increased alveolar nitric oxide in early systemic sclerosis.

Wuttge DM, Bozovic G, Hesselstrand R, Aronsson D, Bjermer L, Scheja A, Tufvesson E.

Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S5-9. Epub 2010 Nov 3.

PMID:
21050538
3.

Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.

Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O.

Arthritis Rheumatol. 2015 Dec;67(12):3256-61. doi: 10.1002/art.39405.

4.

Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease.

Girgis RE, Gugnani MK, Abrams J, Mayes MD.

Am J Respir Crit Care Med. 2002 Jun 15;165(12):1587-91.

PMID:
12070057
5.

Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.

Tiev KP, Cabane J, Aubourg F, Kettaneh A, Ziani M, Mouthon L, Duong-Quy S, Fajac I, Guillevin L, Dinh-Xuan AT.

Eur Respir J. 2007 Jul;30(1):26-30. Epub 2007 Apr 11.

6.

Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement.

Malerba M, Radaeli A, Ragnoli B, Airo' P, Corradi M, Ponticiello A, Zambruni A, Grassi V.

Chest. 2007 Aug;132(2):575-80. Epub 2007 Jun 5.

PMID:
17550935
7.

[Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].

Hua-Huy T, Rivière S, Tiev KP, Dinh-Xuan AT.

Rev Pneumol Clin. 2014 Dec;70(6):335-42. doi: 10.1016/j.pneumo.2014.09.003. Epub 2014 Nov 20. Review. French.

PMID:
25457218
8.

Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?

Guilleminault L, Saint-Hilaire A, Favelle O, Caille A, Boissinot E, Henriet AC, Diot P, Marchand-Adam S.

Respir Med. 2013 Nov;107(11):1789-96. doi: 10.1016/j.rmed.2013.07.007. Epub 2013 Sep 5.

9.

Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma.

Tiev KP, Hua-Huy T, Kettaneh A, Allanore Y, Le-Dong NN, Duong-Quy S, Cabane J, Dinh-Xuan AT.

Thorax. 2012 Feb;67(2):157-63. doi: 10.1136/thoraxjnl-2011-200499. Epub 2011 Oct 24.

PMID:
22026971
10.

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.

Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S111-6. Epub 2015 Aug 5.

PMID:
26243401
11.

Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.

Guarnieri G, Zanatta E, Mason P, Scarpa MC, Pigatto E, Maestrelli P, Cozzi F.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S80-6. Epub 2015 Apr 16.

PMID:
25897784
12.

Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis.

Tiev KP, Le-Dong NN, Duong-Quy S, Hua-Huy T, Cabane J, Dinh-Xuan AT.

Nitric Oxide. 2009 May;20(3):200-6. doi: 10.1016/j.niox.2008.11.004. Epub 2008 Dec 7.

PMID:
19100854
13.

Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.

Pernot J, Puzenat E, Magy-Bertrand N, Manzoni P, Gondouin A, Bourdin H, Simon-Rigaud ML, Regnard J, Degano B.

Respiration. 2012;84(6):461-8. doi: 10.1159/000335473. Epub 2012 Jan 31.

14.

Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.

Pinal-Fernandez I, Pallisa-Nuñez E, Selva-O'Callaghan A, Castella-Fierro E, Simeon-Aznar CP, Fonollosa-Pla V, Vilardell-Tarres M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S136-41. Epub 2015 Aug 27.

PMID:
26315813
15.

Interstitial lung disease in systemic sclerosis: a simple staging system.

Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU.

Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.

PMID:
18369202
16.

Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension.

Rolla G, Colagrande P, Scappaticci E, Chiavassa G, Dutto L, Cannizzo S, Bucca C, Morello M, Bergerone S, Bardini D, Zaccagna A, Puiatti P, Fava C, Cortese G.

J Rheumatol. 2000 Jul;27(7):1693-8.

PMID:
10914853
17.

Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease.

Tiev KP, Rivière S, Hua-Huy T, Cabane J, Dinh-Xuan AT.

Nitric Oxide. 2014 Aug 31;40:17-21. doi: 10.1016/j.niox.2014.04.011. Epub 2014 May 14.

PMID:
24831352
18.

Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.

Kennedy B, Branagan P, Moloney F, Haroon M, O'Connell OJ, O'Connor TM, O'Regan K, Harney S, Henry MT.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):228-36.

PMID:
26422568
19.

Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study.

Ariani A, Silva M, Bravi E, Saracco M, Parisi S, De Gennaro F, Lumetti F, Idolazzi L, Seletti V, Caramaschi P, Benini C, Bodini FC, Scirè CA, Lucchini G, Santilli D, Mozzani F, Imberti D, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Sverzellati N.

Mod Rheumatol. 2015 Sep;25(5):724-30. doi: 10.3109/14397595.2015.1016200. Epub 2015 May 5.

PMID:
25736361
20.

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis.

Barskova T, Gargani L, Guiducci S, Randone SB, Bruni C, Carnesecchi G, Conforti ML, Porta F, Pignone A, Caramella D, Picano E, Cerinic MM.

Ann Rheum Dis. 2013 Mar;72(3):390-5. doi: 10.1136/annrheumdis-2011-201072. Epub 2012 May 15.

PMID:
22589373

Supplemental Content

Support Center